Hang it in the Louvre Jalen Brunson said goodbye to Detroit and JB Bitcherstaff

As a Knicks Fan this might be the funniest thing I've ever seen

$QURE "As the Company advances its pipeline and AMT-130 toward a BLA submission and potential commercialization, uniQure is initiating quarterly earnings calls to provide regular updates on progress and to enhance engagement with the investment community." uniqure.gcs-web.com/news-releases/…

JALEN. BRUNSON.

The Knicks are 1-0 against the top 3 teams in the NBA when it matters

🤔🤔

One more point for the Celtics and Game 3 at the Mecca can officially begin! Lg Knicks!!! #Knicks #BrunsonBurner

TYRESE HALIBURTON WHERE TF YOU AT

Knicks in 6

$QURE is assembling the perfect business unit for a future acquisition. Don’t just watch who they’re hiring, but where they come from. It’s what you know and who you know! This is how big pharma moves. The only question now: which company is going to buy them? Place your bets. 👇

This animation demonstrates how AMT-260, uniQure's investigational gene therapy for the treatment of mesial temporal lobe epilepsy, is delivered into a part of the brain called the hippocampus. $QURE #TLE youtube.com/watch?v=Ph59Gg…

Man this 3-1 comeback by the Knicks is going to be legendary. Historic.

Today we'll present a clinical case study of the first participant dosed in the ongoing trial of #genetherapy AMT-260 in MTLE, showing no serious adverse events and 92% reduction in seizure frequency through the first five months of follow up. #epilepsy uniqure.gcs-web.com/news-releases/…

Wow! First patient #Epilepsy data: “From ~35 seizures (~7/month) before receiving AMT-260 ➡️ to just 2 in 5 months after.” Heading to another accelerated approval. $QURE & $CLPT emerging as platform winners! 🚀 Press release: uniqure.gcs-web.com/news-releases/… #GeneTherapy

$QURE "BLA #Huntington planned for 1Q26". "FDA continues to support Accelerated Approval pathway". "Efficacy evaluates 3yr in high-dose patients". "Validation of manufacturing process possible using experience from HEMGENIX process". Press + webcast: uniqure.gcs-web.com/news-releases/… $CLPT

This stuff has dried up completely and I’ll be breaking it tomorrow night… What do you say we hit a $100,000 or more gem??!! whatnot.com/s/lF80SDhm

$QURE “This was the best decision I ever made”, one Haemophilia B patient expressed, during a recent follow-up. 🙏 These patient updates mean everything — may this be just the beginning, with many more hopeful stories to come for patients with Huntington, Fabry, Epilepsy and ALS.

Today at the International #Epilepsy Congress poster session, uniQure's Dr. Firas Taha presented a case study on the GenTLE Phase I/IIa Clinical Trial of our #genetherapy AMT-260. #IEC2025

Thinking about this innovation in preparing my first blog post in 3 years "In Neurona Therapeutics’ Phase 1/2 clinical trial for NRTX-1001, a regenerative neural cell therapy for drug-resistant mesial temporal lobe epilepsy (MTLE), one patient with a 7-year history of seizures,

Freddie is looking down and giving y'all a standing ovation. That's spectacular!😍💗 The most INSANE Bohemian Rhapsody Flashmob you will ever see!! With 30 musicians and singers in the STREET of Paris 😍 Cre : Julien Cohen Pianist